CHINA MEDICAL UNIVERSITY HOSPITAL
Clinical Trials
417
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (303 trials with phase data)• Click on a phase to view related trials
Effects of Maca Supplementation on Badminton-specific Exercise Performance
- Conditions
- HealthyAthletes
- First Posted Date
- 2025-07-24
- Last Posted Date
- 2025-07-24
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT07082985
- Locations
- 🇨🇳
China Medical University, Taichung, Taiwan
Applying Interactive E-books on Breastfeeding to Enhance Nursing Students' Learning
- Conditions
- Nursing Education ResearchNursing StudentsBreastfeeding Education
- First Posted Date
- 2025-07-17
- Last Posted Date
- 2025-07-17
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT07071285
- Locations
- 🇨🇳
China Medical University, Taichung, Taiwan
Observe the Effects of Far Infrared Eye Masks on Acupoints Around the Eyes in Patients With Dry Eye Syndrome
- Conditions
- Dry Eye Disease (DED)
- First Posted Date
- 2025-07-11
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 45
- Registration Number
- NCT07060131
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, North Dist, Taiwan
Effectiveness of Bilateral Modified Catheter Antegrade Cerebral Perfusion in Acute Type A Aortic Dissection Surgery
- Conditions
- Acute Type A Aortic Dissection
- First Posted Date
- 2025-06-29
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 274
- Registration Number
- NCT07043777
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
Investigating Chinese Herbal Medicine for Modulating Gut Microbiota in Treating Inflammatory Bowel Disease: Molecular Mechanisms and Clinical Study
- Conditions
- IBD - Inflammatory Bowel Disease
- Interventions
- Drug: BXD treatment
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT07035613
- Locations
- 🇨🇳
China medicial university hospital, Taichung, Taiwan
- Prev
- 1
- 2
- 3
- 4
- 5
- 84
- Next
News
World's First HLA-G Targeted Exosome Therapy SOB100 Receives FDA Approval for Phase I Cancer Trials
SOB100, developed by China Medical University Hospital and Shine-On Biomedical, represents the world's first exosome-based drug delivery platform specifically targeting HLA-G for cancer treatment.
Avance Clinical Expands Asia-Pacific Footprint with Four Strategic Partnerships in Taiwan
Avance Clinical, a global Contract Research Organization, has signed Memorandums of Understanding with four premier Taiwanese medical institutions, strengthening its GlobalReady model for biotech companies.
St Vincent's Melbourne and CMUH Forge International Partnerships to Advance Clinical Research
St Vincent's Hospital Melbourne has established a partnership with China's Sichuan Provincial People's Hospital to conduct joint multi-center clinical trials focusing on drugs, medical devices, and digital solutions.